Lymphomas Clinical Trials

51 clinical trials for Lymphomas across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer — RECRUITING
• A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas — RECRUITING · PHASE1
• Collection of Tissue Samples for Cancer Research — RECRUITING
• Interest of Individual Biomarkers From the Identification of Tumor Genotype by High-throughput Molecular Techniques — RECRUITING · NA
• Selinexor, High-dose Methotrexate, and Rituximab Combined With Radiotherapy for Newly Diagnosed, Transplant-ineligible Patients With Central Nervous System Lymphoma: An Open-label, Single-arm, Multicenter Phase II Study — RECRUITING · PHASE2
• Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors — COMPLETED · PHASE1
• Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas — COMPLETED · PHASE1
• Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors — COMPLETED · PHASE1
• Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects — COMPLETED · PHASE1
• CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors — NOT_YET_RECRUITING · PHASE1
• TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas — COMPLETED · PHASE1
• Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology — COMPLETED
• A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors — OTHER · NA
• A Study of HMPL-689 in Patients With Lymphomas Failed of Standard of Care or no Standard of Care Existed — COMPLETED · PHASE1
• A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval — COMPLETED · PHASE1
• T-cell Depleted Alternative Donor Transplantation — TERMINATED · PHASE2
• Nonmyeloablative Haploidentical Transplant Followed by MLN9708 — COMPLETED · PHASE2
• Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant — TERMINATED
• Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas — COMPLETED · PHASE1
• A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma. — COMPLETED · PHASE1
• tTF-NGR Phase I Study — COMPLETED · PHASE1
• Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT — WITHDRAWN · PHASE1
• Refinement of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Via Cognitive Interviewing and Usability Testing — COMPLETED
• Post Transplant Donor Lymphocyte Infusion — TERMINATED · PHASE2
• Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction — COMPLETED · PHASE1
• A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas — COMPLETED · PHASE1
• A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas — COMPLETED · PHASE1
• Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy — COMPLETED · PHASE2
• Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas — COMPLETED · PHASE2
• Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma — COMPLETED · PHASE1
• Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas — COMPLETED · PHASE1
• A Study to Determine the Metabolism and Elimination of 14C-E7080 in Patients With Advanced Solid Tumors or Lymphomas, Who Are Unsuitable For, or Have Failed, Existing Therapies. — COMPLETED · PHASE1
• Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation. — COMPLETED · NA
• A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001 — TERMINATED · PHASE1
• Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma — COMPLETED · PHASE1
• Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas — WITHDRAWN · PHASE1
• CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273) — OTHER · PHASE1
• Bronchoscopic Sampling Techniques in Sarcoidosis — OTHER · NA
• A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma — COMPLETED · PHASE1
• Virtual Bronchoscopy (VB) vs. Endobronchial Ultrasound (EBUS) Guided Mediastinal Sampling — OTHER · NA
• Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies — TERMINATED
• Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting — COMPLETED · PHASE2
• Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas — OTHER
• Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas — OTHER · PHASE1
• Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas — COMPLETED · PHASE1
• Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours — WITHDRAWN · PHASE1
• Assess the Oral Bioavailability of New ABT-263 Formulations — COMPLETED · PHASE1
• R Retreatment in 1st Relapsed DLBCL — OTHER · PHASE2
• Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas — COMPLETED · NA
• Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy — COMPLETED · PHASE1

Refine this search